Influence of glucagon-like peptide-2 on intestinal lymphocyte homing in mice with acute pancreatitis

OBJECTIVE: To investigate the influence of glucagon-like peptide-2 (GLP-2) on intestinal lymphocyte homing receptor-integrin alpha 4 beta 7 and homing ligand-intestinal mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in mice with acute pancreatitis (AP)

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 21(2009), 2 vom: 17. Feb., Seite 103-6
1. Verfasser: Kong, Ling-shang (VerfasserIn)
Weitere Verfasser: Liu, Mu-lin, Zhang, Zong-bing, Chen, De-li, Liu, Rui-lin
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Glucagon-Like Peptide 2 Immunoglobulins Integrins Mucoproteins integrin alpha4beta7
LEADER 01000caa a22002652 4500
001 NLM186468512
003 DE-627
005 20250210050237.0
007 tu
008 231223s2009 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0622.xml 
035 |a (DE-627)NLM186468512 
035 |a (NLM)19220963 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Kong, Ling-shang  |e verfasserin  |4 aut 
245 1 0 |a Influence of glucagon-like peptide-2 on intestinal lymphocyte homing in mice with acute pancreatitis 
264 1 |c 2009 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 06.05.2010 
500 |a Date Revised 01.12.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To investigate the influence of glucagon-like peptide-2 (GLP-2) on intestinal lymphocyte homing receptor-integrin alpha 4 beta 7 and homing ligand-intestinal mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in mice with acute pancreatitis (AP) 
520 |a METHODS: A total of 96 mice were divided into three groups randomly (n=32 in each group): AP group, GLP-2 group and control group. Murine AP model was reproduced by intraperitoneal injection of caerulein and lipopolysaccharides (LPS). GLP-2 (250 microg/kg) was injected intraperitoneally at 15 minutes after the establishment of model, then it was injected twice a day for 3 days in GLP-2 group, while the mice in control group received normal saline instead. Mice were sacrificed at 6, 12, 24 and 48 hours after reproduction of AP, and tissue specimens were harvested. Integrin alpha 4 beta 7 positive peripheral blood lymphocytes were determined by flow cytometry. The expression of MAdCAM-1 in the terminal ileum mucosa and Peyer patch was measured by immunohistochemistry. Same observations were also done in the control and GLP-2 groups 
520 |a RESULTS: Compared with control group, integrin alpha 4 beta 7 positive lymphocyte in peripheral blood and the expression of MAdCAM-1 in the terminal ileum mucosa and Peyer patch were significantly reduced at 6, 12, 24 and 48 hours in AP mice (all P<0.05). Integrin alpha 4 beta 7 positive lymphocyte and the expression of MAdCAM-1 were markedly higher in GLP-2 group than those in AP group (all P<0.05), but were lower in GLP-2 group than those in control group (all P>0.05) 
520 |a CONCLUSION: Administration of GLP-2 may restore expression of integrin alpha 4 beta 7 and MAdCAM-1, promote lymphocyte homing to intestine, thus improve the immunological function of intestine 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Glucagon-Like Peptide 2  |2 NLM 
650 7 |a Immunoglobulins  |2 NLM 
650 7 |a Integrins  |2 NLM 
650 7 |a Mucoproteins  |2 NLM 
650 7 |a integrin alpha4beta7  |2 NLM 
700 1 |a Liu, Mu-lin  |e verfasserin  |4 aut 
700 1 |a Zhang, Zong-bing  |e verfasserin  |4 aut 
700 1 |a Chen, De-li  |e verfasserin  |4 aut 
700 1 |a Liu, Rui-lin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 21(2009), 2 vom: 17. Feb., Seite 103-6  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:21  |g year:2009  |g number:2  |g day:17  |g month:02  |g pages:103-6 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 21  |j 2009  |e 2  |b 17  |c 02  |h 103-6